You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,713,394


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,713,394
Title: Treatment of nonacne inflammatory and infectious dermatoses and hair loss
Abstract:Dermatoses involving nonacne inflammatory dermatoses, infectious cutaneous diseases, and hair loss resulting from inflammation or hormonal anomalies are treated with dicarboxylic acids containing 7 to 13 carbon atoms, or certain mercapto derivatives or salts thereof.
Inventor(s): Thornfeldt; Carl R. (Ontario, OR)
Assignee:
Application Number:06/873,859
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,713,394: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for both patent holders and those seeking to navigate the intellectual property landscape. This article will delve into the details of United States Patent 4,713,394, exploring its claims, the patent landscape, and the implications for stakeholders.

Background of the Patent

United States Patent 4,713,394, though not explicitly detailed in the provided sources, typically involves a specific invention or innovation. To analyze this patent, one must review the patent document itself, focusing on the background, summary, detailed description, and claims.

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of protection. Claims in a patent like 4,713,394 are typically divided into independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations[3].

Claim Interpretation

Claim interpretation is a critical step in understanding the patent's scope. This involves construing the claim terms to determine their meaning and application. The Federal Circuit has established that claim construction is a question of law, reviewed de novo on appeal[2].

Claim Coverage Matrix

To effectively analyze the claims of a patent like 4,713,394, a Claim Coverage Matrix can be useful. This matrix categorizes patents by claims and overarching scope concepts, helping to identify which claims actively protect the intellectual property and where gaps or opportunities exist[3].

Patent Landscape

Related Patents and Continuations

Understanding the patent landscape involves identifying related patents, continuations, and continuations-in-part. For example, in the case of In re Cellect, multiple patents were part of the same family, with some being continuations-in-part of earlier patents. This can impact the patent term and obviousness-type double patenting (ODP) analysis[1].

Prior Art and Anticipation

The patent landscape also includes prior art and potential anticipation issues. If a patent's claims are found to be anticipated by prior art, they may be deemed unpatentable. This was a key issue in cases like Vascular Solutions LLC v. Medtronic, Inc., where the validity of claims was challenged based on prior art[2].

Obviousness-Type Double Patenting (ODP)

ODP is a critical consideration when analyzing patents within the same family. The Federal Circuit has ruled that ODP analysis must be performed on patents that have been granted Patent Term Adjustment (PTA), considering the expiration date of the patent with and without PTA[1].

Claim Construction and Indefiniteness

Claim construction and indefiniteness are legal conclusions that must be carefully evaluated. The court must construe claims on a claim-by-claim basis, ensuring that the terms are clear and do not confuse a person skilled in the field. Indefiniteness, if found, can render claims unpatentable[2].

Practical Applications and Patent Eligibility

For patents involving innovative technologies, such as AI, the USPTO's updated guidance is crucial. The guidance provides examples of patent-eligible and ineligible claims, helping practitioners draft claims that meet the subject matter eligibility criteria. Demonstrating real-world applications and concrete benefits is key to establishing patent eligibility[4].

Strategic Implications

Identifying Gaps and Opportunities

Using tools like Claim Coverage Matrix and Claim Charts, companies can identify gaps in their current patent coverage and highlight future design opportunities. This helps in strategic decision-making, such as determining which patents to maintain or pursue[3].

Managing Patent Portfolios

Effective management of a patent portfolio involves regularly reviewing and updating claim charts as new patents are filed or as development avenues are explored. This ensures that the company's intellectual property remains aligned with its business objectives[3].

Key Takeaways

  • Claims Analysis: Understanding the structure and interpretation of claims is essential for determining the scope of protection.
  • Patent Landscape: Identifying related patents, prior art, and ODP issues is crucial for navigating the intellectual property landscape.
  • Claim Construction: Clear and consistent claim construction is vital to avoid indefiniteness and ensure patent validity.
  • Strategic Implications: Regularly reviewing and updating patent coverage helps in identifying gaps and opportunities, ensuring alignment with business objectives.

FAQs

What is the importance of claim construction in patent analysis?

Claim construction is crucial as it determines the meaning and application of claim terms, affecting the scope of protection and validity of the patent.

How does obviousness-type double patenting (ODP) impact patent validity?

ODP can render claims unpatentable if they are found to be obvious over earlier patents within the same family, especially when considering Patent Term Adjustments.

What role does the USPTO's updated guidance play in AI patent eligibility?

The USPTO's guidance provides clear examples and criteria for determining the patent eligibility of AI-related inventions, helping practitioners draft claims that meet the subject matter eligibility criteria.

How can a Claim Coverage Matrix benefit patent holders?

A Claim Coverage Matrix helps patent holders identify which patents and claims actively protect their intellectual property, spot gaps in coverage, and highlight future design opportunities.

What is the significance of prior art in patent analysis?

Prior art can anticipate patent claims, rendering them unpatentable. Therefore, thorough prior art searches are essential during the patent application process.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Vascular Solutions LLC v. Medtronic, Inc., United States Court of Appeals for the Federal Circuit, September 16, 2024.
  3. Patent Analytics, Schwegman, Lundberg & Woessner, P.A.
  4. Understanding the 2024 USPTO Guidance Update on AI Patent, Mintz, July 25, 2024.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,713,394

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,713,394

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 229654 ⤷  Subscribe
Germany 3750934 ⤷  Subscribe
Germany 3751780 ⤷  Subscribe
European Patent Office 0229654 ⤷  Subscribe
European Patent Office 0593093 ⤷  Subscribe
Japan 2505983 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.